Monkeypox Treatment Market
According to Intent Market Research, the Monkeypox Treatment Market is expected to grow from USD 0.3 Billion in 2024-e at a CAGR of 15.4% to touch USD 0.8 Billion by 2030. The Monkeypox Treatment Market is dominated by key players such as, Bavarian Nordic, Emergent BioSolutions, Johnson & Johnson, Inovio Pharmaceuticals, Moderna, and Sanofi.